Clinical trials
Phase 2/3 Burkitt Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Unknown status | 2 |
| Completed | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Fujian Medical University | 1 |
| Gilead Sciences | 1 |
| Health Institutes of Turkey | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cancer Institute (NCI) | 1 |
| Roswell Park Cancer Institute | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Large-Cell, Immunoblastic | 2 |
| Lymphoma, Mantle-Cell | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.